Sat, Sep 20, 2014, 4:08 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

pwstan 5 posts  |  Last Activity: Sep 17, 2014 7:17 PM Member since: Feb 23, 2000
  • Reply to

    Weak Hands Flushed Out

    by kz7m Sep 17, 2014 6:04 PM
    pwstan pwstan Sep 17, 2014 7:17 PM Flag

    I for one would love to see the company sold at 3.50 per share right now. But it's not gonna happen in my opinion. I am hugely (is that a word) long, for 15 years, and I can't imagine any company ante-ing up that kind of money for the continuously "interesting", "very interesting", etc, etc, results that this company has delivered. Thompson has already said, in a reply to one of the posters on the V2 board, when asked if Saab would have new information, "I am not sure what he will talk about beyond safety and the overall PFS, so nothing new." Why expect more??

    I'm really disappointed in how this turned out. But ya got to take off the rose colored gl#$%$es eventually. I'll listen to Saab, or read about his poster board, but if it's not really good, time to cut bait. And I'm already kicking myself in the #$%$ for waiting this long.

  • Reply to

    Feel really good about the future prospects!

    by biotechqqqq Aug 22, 2014 10:46 PM
    pwstan pwstan Aug 24, 2014 9:00 PM Flag

    Yours has got to be the biggest bunch of horse manure that anyone has planted on this non-fertile ground in eons. Good grief!

    You say "a great biotech company". Please tell us what makes it great?? The leadership. Uh-uh!. They just finished relieving their long tenured CEO of his job (we all rejoiced, but the vote is still out on his replacement). Virtually no one on the staff or the board ever buys shares on the open market. Gee, there's a real shot to the arm for long suffering longs.

    You say "an amazing pipeline". Every drug these guys have ever produced or bought has taken eons to test. The one drug, Erivedge, that was commercialed was accomplished by Roche, not CRIS. And the contract for the royalties of this drug was negotiated by that "great biotech company" that you claim they are, starts at 5% and may, maybe, if we all go out and sit in the sun for many years and develop advanced melanoma, could rise to 7.5%, You believe in 427. Possibly, yes. Possibly 10-15 years from now if their phase 1 can get re-started and enrolled. What you say, hsp-90. Try to find that anywhere enrolling like wildfire. Oh, I know what you're thinking of. Their newly acquired IDP drug that's going into Phase II. I will say this. It has promise, if only someone else could run the trial. Even though they say early 2015 results, based upon past performance, I'd be happy with early 2016.

    Negative am I? Cynical? You better believe it. Have been invested in this company for a real long time. I bailed on 66% of my stock at $3.30. Was really stupid to hang on to 33%. I will completely bail just as fast as I can. I like the products, I despise the management and the board. They seem like figureheads to me, a rudderless ship, or perhaps, just really selfish, lazy, stupid people.

    My 2 cents.

  • pwstan pwstan Aug 21, 2014 6:36 PM Flag

    To most of us here, you're just plain ignorant

  • Reply to

    Yo, Armed

    by pwstan Aug 19, 2014 4:27 PM
    pwstan pwstan Aug 19, 2014 5:41 PM Flag


  • pwstan by pwstan Aug 19, 2014 4:27 PM Flag

    Hey, I'm a bit concerned about D2. Have not heard from him anywhere in quite some time, including private emails. If you want to chat offline, my handle and I use Yahoo.


1.52-0.04(-2.56%)Sep 19 4:15 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.